Literature DB >> 19184383

Conformational isomers of denatured and unfolded proteins: methods of production and applications.

Jui-Yoa Chang1.   

Abstract

Conformational isomers of denatured-unfolded proteins are rich in numbers and varied in shapes. They represent an opulent resource of biological molecules that have remained unexploited. The major obstacle in utilizing this untapped potential is that it is inherently difficult to isolate and characterize pure conformational isomers, not only because of the excessive large number, but also because of their instability and rapid inter-conversion. Our lab has developed a method for trapping selected conformational isomers of denatured proteins that are amenable to isolation, characterization and further applications. The method has potential usefulness, ranging from the comprehensive structural characterization of denatured proteins, to the elucidation of pathways of protein unfolding-folding, to the production of unlimited structurally defined non-native protein isomers for biomedical applications.

Mesh:

Substances:

Year:  2009        PMID: 19184383     DOI: 10.1007/s10930-009-9162-7

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  96 in total

1.  Solution structure of a protein denatured state and folding intermediate.

Authors:  T L Religa; J S Markson; U Mayor; S M V Freund; A R Fersht
Journal:  Nature       Date:  2005-10-13       Impact factor: 49.962

2.  A 3-disulfide mutant of mouse prion protein expression, oxidative folding, reductive unfolding, conformational stability, aggregation and isomerization.

Authors:  Bao-Yuan Lu; Jui-Yoa Chang
Journal:  Arch Biochem Biophys       Date:  2007-02-05       Impact factor: 4.013

Review 3.  The protein folding problem.

Authors:  Ken A Dill; S Banu Ozkan; M Scott Shell; Thomas R Weikl
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

4.  Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition.

Authors:  M A Speed; D I Wang; J King
Journal:  Nat Biotechnol       Date:  1996-10       Impact factor: 54.908

Review 5.  Intermediates in the folding reactions of small proteins.

Authors:  P S Kim; R L Baldwin
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

6.  The structure of denatured bovine pancreatic trypsin inhibitor (BPTI).

Authors:  J Chang; A Ballatore
Journal:  FEBS Lett       Date:  2000-05-12       Impact factor: 4.124

Review 7.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 8.  Protein disulfide isomerase.

Authors:  Bonney Wilkinson; Hiram F Gilbert
Journal:  Biochim Biophys Acta       Date:  2004-06-01

9.  NMR analysis of the residual structure in the denatured state of an unusual mutant of staphylococcal nuclease.

Authors:  D Shortle; C Abeygunawardana
Journal:  Structure       Date:  1993-10-15       Impact factor: 5.006

Review 10.  Protein misfolding and neurodegeneration.

Authors:  Claudio Soto; Lisbell D Estrada
Journal:  Arch Neurol       Date:  2008-02
View more
  3 in total

1.  Effects of Metal Ions, Temperature, and a Denaturant on the Oxidative Folding Pathways of Bovine α-Lactalbumin.

Authors:  Reina Shinozaki; Michio Iwaoka
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

2.  Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels.

Authors:  Chuantao Jiang; Hersharan Nischal; Hua Sun; Li Li; Ying Cao; Peng Wei; Jui-Yoa Chang; Ba-Bie Teng
Journal:  Int J Mol Sci       Date:  2018-02-24       Impact factor: 5.923

3.  Hydrogen bonds are a primary driving force for de novo protein folding.

Authors:  Schuyler Lee; Chao Wang; Haolin Liu; Jian Xiong; Renee Jiji; Xia Hong; Xiaoxue Yan; Zhangguo Chen; Michal Hammel; Yang Wang; Shaodong Dai; Jing Wang; Chengyu Jiang; Gongyi Zhang
Journal:  Acta Crystallogr D Struct Biol       Date:  2017-11-10       Impact factor: 7.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.